ASAM-magazine-Header

American Society of Addiction Medicine Announces New EVP/CEO

by ASAM Staff | Apr 28, 2020

Download Release

 

(Rockville, MD) - The American Society of Addiction Medicine (ASAM) proudly announces the appointment of Julia L. Chang, MBA, MS as the organization’s new EVP/CEO beginning May 27, 2020. She will succeed Penny S. Mills, MBA who is retiring after 10 years of dedicated and transformative leadership to ASAM.

 

“Julia Chang is the right leader for ASAM,” said ASAM President Dr. Paul Earley. “Her science and consulting background combined with her most recent association expertise make her an excellent fit for ASAM’s current and future needs.”

 

Julia L. Chang MBA, MS is currently the Executive Vice President of the science and quality division at the American College of Cardiology (ACC). She brings over 20 years of association management and corporate business experience. During her career, she led her division to become the largest and most profitable area at ACC. Her scope included overseeing educational events, publishing over 50 observational research articles annually, updating over 30 clinical guidelines, launching 10 mobile apps for clinicians, and expanding hospitals participation in clinical registries and accreditation.

 

Prior to ACC, Julia spent over 5 years as a senior management consultant with IBM’s Strategy & Change Practice division where she managed high-visibility strategy and business planning projects, leading teams of consultants in marketing, sales, and R&D.

 

"For many years, the passionate members and talented staff of the American Society of Addiction Medicine have been growing their mission to new heights,” said Julia L. Chang. “It is an honor and privilege to join these professionals who have dedicated their careers to people suffering from addiction.”

 

About ASAM

The American Society of Addiction Medicine, founded in 1954, is a professional medical society representing over 6,500 physicians, clinicians and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.

 

###

 

Contact: Christine Merrifield

press@ASAM.org
301.547.4140

Quality & Science

American Society of Addiction Medicine Announces New EVP/CEO

by ASAM Staff | Apr 28, 2020

Download Release

 

(Rockville, MD) - The American Society of Addiction Medicine (ASAM) proudly announces the appointment of Julia L. Chang, MBA, MS as the organization’s new EVP/CEO beginning May 27, 2020. She will succeed Penny S. Mills, MBA who is retiring after 10 years of dedicated and transformative leadership to ASAM.

 

“Julia Chang is the right leader for ASAM,” said ASAM President Dr. Paul Earley. “Her science and consulting background combined with her most recent association expertise make her an excellent fit for ASAM’s current and future needs.”

 

Julia L. Chang MBA, MS is currently the Executive Vice President of the science and quality division at the American College of Cardiology (ACC). She brings over 20 years of association management and corporate business experience. During her career, she led her division to become the largest and most profitable area at ACC. Her scope included overseeing educational events, publishing over 50 observational research articles annually, updating over 30 clinical guidelines, launching 10 mobile apps for clinicians, and expanding hospitals participation in clinical registries and accreditation.

 

Prior to ACC, Julia spent over 5 years as a senior management consultant with IBM’s Strategy & Change Practice division where she managed high-visibility strategy and business planning projects, leading teams of consultants in marketing, sales, and R&D.

 

"For many years, the passionate members and talented staff of the American Society of Addiction Medicine have been growing their mission to new heights,” said Julia L. Chang. “It is an honor and privilege to join these professionals who have dedicated their careers to people suffering from addiction.”

 

About ASAM

The American Society of Addiction Medicine, founded in 1954, is a professional medical society representing over 6,500 physicians, clinicians and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.

 

###

 

Contact: Christine Merrifield

press@ASAM.org
301.547.4140

Education

American Society of Addiction Medicine Announces New EVP/CEO

by ASAM Staff | Apr 28, 2020

Download Release

 

(Rockville, MD) - The American Society of Addiction Medicine (ASAM) proudly announces the appointment of Julia L. Chang, MBA, MS as the organization’s new EVP/CEO beginning May 27, 2020. She will succeed Penny S. Mills, MBA who is retiring after 10 years of dedicated and transformative leadership to ASAM.

 

“Julia Chang is the right leader for ASAM,” said ASAM President Dr. Paul Earley. “Her science and consulting background combined with her most recent association expertise make her an excellent fit for ASAM’s current and future needs.”

 

Julia L. Chang MBA, MS is currently the Executive Vice President of the science and quality division at the American College of Cardiology (ACC). She brings over 20 years of association management and corporate business experience. During her career, she led her division to become the largest and most profitable area at ACC. Her scope included overseeing educational events, publishing over 50 observational research articles annually, updating over 30 clinical guidelines, launching 10 mobile apps for clinicians, and expanding hospitals participation in clinical registries and accreditation.

 

Prior to ACC, Julia spent over 5 years as a senior management consultant with IBM’s Strategy & Change Practice division where she managed high-visibility strategy and business planning projects, leading teams of consultants in marketing, sales, and R&D.

 

"For many years, the passionate members and talented staff of the American Society of Addiction Medicine have been growing their mission to new heights,” said Julia L. Chang. “It is an honor and privilege to join these professionals who have dedicated their careers to people suffering from addiction.”

 

About ASAM

The American Society of Addiction Medicine, founded in 1954, is a professional medical society representing over 6,500 physicians, clinicians and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.

 

###

 

Contact: Christine Merrifield

press@ASAM.org
301.547.4140

Advocacy and Policy

American Society of Addiction Medicine Announces New EVP/CEO

by ASAM Staff | Apr 28, 2020

Download Release

 

(Rockville, MD) - The American Society of Addiction Medicine (ASAM) proudly announces the appointment of Julia L. Chang, MBA, MS as the organization’s new EVP/CEO beginning May 27, 2020. She will succeed Penny S. Mills, MBA who is retiring after 10 years of dedicated and transformative leadership to ASAM.

 

“Julia Chang is the right leader for ASAM,” said ASAM President Dr. Paul Earley. “Her science and consulting background combined with her most recent association expertise make her an excellent fit for ASAM’s current and future needs.”

 

Julia L. Chang MBA, MS is currently the Executive Vice President of the science and quality division at the American College of Cardiology (ACC). She brings over 20 years of association management and corporate business experience. During her career, she led her division to become the largest and most profitable area at ACC. Her scope included overseeing educational events, publishing over 50 observational research articles annually, updating over 30 clinical guidelines, launching 10 mobile apps for clinicians, and expanding hospitals participation in clinical registries and accreditation.

 

Prior to ACC, Julia spent over 5 years as a senior management consultant with IBM’s Strategy & Change Practice division where she managed high-visibility strategy and business planning projects, leading teams of consultants in marketing, sales, and R&D.

 

"For many years, the passionate members and talented staff of the American Society of Addiction Medicine have been growing their mission to new heights,” said Julia L. Chang. “It is an honor and privilege to join these professionals who have dedicated their careers to people suffering from addiction.”

 

About ASAM

The American Society of Addiction Medicine, founded in 1954, is a professional medical society representing over 6,500 physicians, clinicians and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.

 

###

 

Contact: Christine Merrifield

press@ASAM.org
301.547.4140

ASAM Weekly Commentary

American Society of Addiction Medicine Announces New EVP/CEO

by ASAM Staff | April 28, 2020

Download Release

 

(Rockville, MD) - The American Society of Addiction Medicine (ASAM) proudly announces the appointment of Julia L. Chang, MBA, MS as the organization’s new EVP/CEO beginning May 27, 2020. She will succeed Penny S. Mills, MBA who is retiring after 10 years of dedicated and transformative leadership to ASAM.

 

“Julia Chang is the right leader for ASAM,” said ASAM President Dr. Paul Earley. “Her science and consulting background combined with her most recent association expertise make her an excellent fit for ASAM’s current and future needs.”

 

Julia L. Chang MBA, MS is currently the Executive Vice President of the science and quality division at the American College of Cardiology (ACC). She brings over 20 years of association management and corporate business experience. During her career, she led her division to become the largest and most profitable area at ACC. Her scope included overseeing educational events, publishing over 50 observational research articles annually, updating over 30 clinical guidelines, launching 10 mobile apps for clinicians, and expanding hospitals participation in clinical registries and accreditation.

 

Prior to ACC, Julia spent over 5 years as a senior management consultant with IBM’s Strategy & Change Practice division where she managed high-visibility strategy and business planning projects, leading teams of consultants in marketing, sales, and R&D.

 

"For many years, the passionate members and talented staff of the American Society of Addiction Medicine have been growing their mission to new heights,” said Julia L. Chang. “It is an honor and privilege to join these professionals who have dedicated their careers to people suffering from addiction.”

 

About ASAM

The American Society of Addiction Medicine, founded in 1954, is a professional medical society representing over 6,500 physicians, clinicians and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction.

 

###

 

Contact: Christine Merrifield

press@ASAM.org
301.547.4140

MOC Guide

Considering a Career in Addiction Medicine?

Physicians who have a primary ABMS board may apply to take the ABPM Addiction Medicine exam to become or continue to be an addiction medicine specialist. Get the latest updates click here.


web-hero-BEST

Board Exam Study Tool

The ASAM Board Examination Study Tool (BEST) helps prepare physicians for the ABPM certification/re-certification examination utilizing an interactive and engaging format. Includes over 700 board-style self-assessment questions and developed, reviewed and mapped to the ABPM exam blueprint content areas by national experts. Learn More>>>


Alcohol withdrawl management

Guideline on Alcohol Withdrawal Management

The ASAM Guideline on Alcohol Withdrawal Management is intended to aid clinicians in their clinical decision making and management of patients experiencing alcohol withdrawal syndrome.


JAM Podcast

Journal of Addiction Medicine March/April 2020

In episode sixteen of Addiction Medicine: Beyond the Abstract, we are joined by Itai Danovitch, MD, MBA. He is the chairman of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles. In his paper, Dr. Danovitch discusses some of the challenges facing the study of opioid overdose events in the hospital setting. Click to listen